Posted by Marta
Allergan (the maker of Botox) has had an eyelash growth product called Latisse in the works for some time and it looks if it will get FDA approval. Take note: Latisse uses the glaucoma drug, bimatoprost, as the active ingredient.
No major safety issues were raised in the FDA review, although four patients in the 278-person clinical study left because of side effects such as dry eye and eye inflammation. Allergan said it would minimize risk by telling doctors and patients about potential drug side effects and instructing users not to use Latisse on lower eyelashes.
The next step towards FDA acceptance was gaining the support of a panel of independent medical experts who met last Friday to vote on Latisse. If they give the all clear it is highly likely that Latisse will reach market because the FDA rarely goes against panel recommendations. This will mean Allergan will become the first company to launch an FDA-approved eyelash enhancer.
